Schering-Plough seminars at IPE

US - Most mainstream poultry companies now use a vaccine for at least part of their coccidiosis-management program in broilers.
calendar icon 7 January 2005
clock icon 3 minute read
In the US, for example, seven of the Top 10 broiler companies have taken this route. Similar trends are being seen in other major poultry markets of Latin America, Europe, Asia and the Middle East.

Initially, most of these companies switched to coccidiosis vaccination to “break up the cycle” of traditional in-feed anticoccidials, many of which were losing effectiveness after continuous use.

Others saw vaccination as a good way to reduce residue risks in the feed mill and to meet growing consumer and regulatory demand to use fewer drugs in animal feeds.

Now, poultry companies are experiencing one more benefit from coccidiosis vaccination:

They’ve discovered that feed programs can be more profitable if they don’t have to work around prescribed treatment regimens and withdrawal times associated with traditional in-feed anticoccidials. In other words, broiler feed programs can be adjusted to meet the needs of the birds, not the requirements of the drug.

To help the worldwide poultry industry learn more about this important benefit, Schering-Plough Animal Health will be hosting two 1-hour seminars at the International Poultry Expo — one in Spanish, the other in English. Breakfast or lunch will also be provided.

Spanish seminar

Thursday, January 27, 8-9 am
Optional breakfast begins at 7:30 am
Georgia World Congress Center
Room C105

English seminar

Thursday, January 27, 12:30-1:30 am
Optional lunch begins at 12 noon
Georgia World Congress Center
Room C212

Contact Joseph Feeks, PR Works for more information: [email protected]

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.